Plasma concentrations of soluble CD40 ligand in smokers with acute myocardial infarction: A pilot study

Heart and Vessels

Volumn 26, Issue 2, 2011, Pages 131-137

  Kayrak, Mehmet ^a   Bacaksiz, Ahmet ^a   Ulgen, Mehmet S ^a   Vatankulu, Mehmet Akif ^a   Zengin, Kadriye ^a   Ayhan, Selim S ^a   Basarali, Mustafa Kemal ^a   Büyükbas, Sadik ^a   Kiyici, Aysel ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Acute myocardial infarction; CD40 ligand; Smoking

Indexed keywords

CD40 LIGAND;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SMOKING;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CD40 LIGAND; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PILOT PROJECTS; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SMOKING; TIME FACTORS; TURKEY; UP-REGULATION;

EID: 79955615241     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-010-0036-x     Document Type: Article

References (32)

1. Doyle JT, Dawber TR, Kannel WB, Heslin AS, Kahn HA (1962) Cigarette smoking and coronary heart disease. N Engl J Med 266:796-801
2. Mohanty D, Shetty S, Anil CR, Pathare A, Ghosh K, Yeolekar ME (1998) Factor V Leiden gene mutation in young Indian patients with myocardial infarction. Curr Sci 74:1078-1079
3. Fitzgerald GA, Jates JA, Nowak J (1988) Cigarette smoking and hemostatic function. Am Heart J 115:267-271
4. Nair S, Kulkarni S, Camoens HMT, Ghosh K, Mohanty D (2001) Changes in platelet receptors after smoking-a flow cytometric study. Platelets 12:20-26 (Pubitemid 32217569)
5. Freedman JE (2003) CD40-CD40L and platelet function: beyond hemostasis. Circ Res 92:944-946
6. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591-594 (Pubitemid 28157601)
7. Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P (1998) Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 394:200-203 (Pubitemid 28325976)
8. Santilli F, Basili S, Ferroni P, Davì G (2007) CD40/CD40L system and vascular disease. Intern Emerg Med 2:256-268
9. Horii M, Uemura S, Uemura M, Matsumoto M, Ishizashi H, Imagawa K, Iwama H, Takeda Y, Kawata H, Nakajima T, Fujimura Y, Saito Y (2008) Acute myocardial infarction as a systemic prothrombotic response condition evidenced by increased von Willebrand factor over ADAMTS13 activity in coronary and systemic circulation. Heart Vessels 23:301-307
10. Ozer N, Tangurek B, Firat F, Ozer S, Tartan Z, Ozturk R, Ozay B, Ciloglu F, Yilmaz H, Cam N (2008) Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention. Heart Vessels 23:75-82 (Pubitemid 351505880)
11. Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, Zeiher AM, Simoons ML (2003) Soluble CD40L ligand in acute coronary syndromes. N Engl J Med 348:1104-1111 (Pubitemid 36337321)
12. André P, Prasad KS, Denis CV, He M, Papalia JM, Hynes RO, Phillips DR, Wagner DD (2002) CD40L stabilizes arterial thrombi by a b3 integrin-dependent mechanism. Nat Med 8:247-252 (Pubitemid 34250102)
13. André P, Nannizzi-Alaimo L, Prasad SK, Phillips DR (2002) Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 106:896-899 (Pubitemid 34925319)
14. Youssef AA, Chang LT, Sheu JJ, Lee FY, Chua S, Yeh KH, Yang CH, Wu CJ, Yip HK (2007) Association between circulating level of CD40 ligand and angiographic morphologic features indicating high-burden thrombus formation in patients with acute myocardial infarction undergoing primary coronary intervention. Circ J 71:1857-1861 (Pubitemid 350261406)
15. Harding SA, Sarma J, Josephs DH, Cruden NL, Din JN, Twomey PJ, Fox KA, Newby DE (2004) Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers. Circulation 109:1926-1929 (Pubitemid 38544479)
16. The TIMI Study Group (1985) The Thrombolysis in Myocardial Infarction (TIMI) trial. N Engl J Med 312:932-936
17. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E (1996) TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93:879-888 (Pubitemid 26074824)
18. Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51:606
19. Celermajer DS, Sorensen KE, Georgapoulos D, Bull C, Thomas O, Robinson J, Deanfield J (1993) Cigarette smoking is associated with dose related and potentially reversible impairment of endothelium dependent dilatation in healthy young adults. Circulation 88(Suppl I):I-2149-I-2155
20. de Lemos JA, Zirlik A, Schönbeck U, Varo N, Murphy SA, Khera A, McGuire DK, Stanek G, Lo HS, Nuzzo R, Morrow DA, Peshock R, Libby P (2005) Association between soluble CD40 ligand, atherosclerosis risk factors and subclinical atherosclerosis. Arterioscler Thromb Vasc Biol 25:2192-2196 (Pubitemid 41416320)
21. Levitzky YS, Guo CY, Rong J, Larson MG, Walter RE, Keaney JF Jr, Sutherland PA, Vasan A, Lipinska I, Evans JC, Benjamin EJ (2008) Relation of smoking status to a panel of inflammatory markers: the Framingham offspring. Atherosclerosis 201:217-224
22. Aukrust P, Müller F, Ueland T, Berget T, Aaser E, Brunsvig A, Solum NO, Forfang K, Frøland SS, Gullestad L (1999) Enhanced levels of soluble and membrane-bound CD40 Ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes. Circulation 100:614-620
23. Varo N, de Lemos JA, Libby P, Morrow DA, Murphy SA, Nuzzo R, Gibson CM, Cannon CP, Braunwald E, Schönbeck U (2003) Soluble CD40L: risk prediction after acute coronary syndromes. Circulation 108:1049-1052 (Pubitemid 37071512)
24. Ishihara M, Sato H, Tateishi H, Kawagoe T, Shimatani Y, Kurisu S, Sakai K, Ueda K (1997) Clinical implications of cigarette smoking in acute myocardial infarction: acute angiographic findings and long-term prognosis. Am Heart J 134:955-960 (Pubitemid 27523002)
25. Leone A (2007) Smoking, haemostatic factors, and cardiovascular risk. Curr Pharm Des 13:1661-1667
26. Tan J, Hua Q, Gao J, Fan ZX (2008) Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction. Clin Cardiol 31:413-418
27. Morrow DA, Sabatine MS, Brennan M, de Lemos JA, Murphy SA, Ruff CT, Rifai N, Cannon CP, Hazen SL (2008) Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18. Eur Heart J 29:1096-1103
28. Nannizzi-Alaimo L, Alves VL, Phillips DR (2003) Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation. Circulation 107:1123-1128 (Pubitemid 36297203)
29. Furman MI, Krueger LA, Linden MD, Barnard MR, Frelinger AL 3rd, Michelson AD (2004) Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization. J Am Coll Cardiol 43:2319-2325 (Pubitemid 38757605)
30. Hasdai D, Holmes DR Jr, Criger DA, Topol EJ, Califf RM, Wilcox RG, Paolasso E, Simoons M, Deckers J, Harrington RA (2000) Cigarette smoking status and outcome among patients with acute coronary syndromes without persistent ST-segment elevation: effect of inhibition of platelet glycoprotein IIb/IIIa with eptifibatide. The PURSUIT trial investigators. Am Heart J 139:454-460 (Pubitemid 30149195)
31. Weisz G, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey TD, Rutherford BD, Mehran R, Aymong E, Lansky A, Grines CL, Stone GW (2005) Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction - the smoker's paradox revisited. Am Heart J 150:358-364 (Pubitemid 41116264)
32. LeeWL, LeeWJ,ChenYT,Liu TJ,LiangKW,TingCT, SheuWHH (2006) The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease. Metabolism 55:1029-1034